On November 20, 2025, Moscow hosted the formal ceremony for the Russian Pharma Awards® — one of the most prestigious awards in the pharmaceutical industry, rightfully known as the «Oscar for Medicine®». The award recipients are determined annually solely by the votes of physicians who are members of the largest professional community, «Doctor at Work®», which unites over 480,000 specialists. The winners across 28 nominations are chosen by practicing doctors, and the awards are also traditionally presented by specialists from the medical community.
Solopharm was recognized as a laureate in two key nominations:
🥈 2nd Place in the «Leader of the Ophthalmic Market in Russia» category
This award reflects the medical community's trust in Solopharm's high quality, innovative approach, and extensive portfolio of ophthalmic solutions. We thank all the physicians who supported us with their votes — your recognition inspires us to continue our development and create even more effective products.
🥉 3rd Place for the drug Tramicent in the «Topical Antibiotic for the Treatment of Sinusitis» category
Tramicent was highlighted by practicing specialists as one of the most effective and convenient solutions for sinusitis therapy. For Solopharm, this is a particularly significant award as it underscores the trust of physicians in the quality and efficacy of the drug.
The Russian Pharma Awards® also supports the social and educational initiatives of pharmaceutical companies, affirming the importance of a comprehensive contribution to the industry's development.
Comment from Solopharm:
«The recognition of the medical community — specialists who make decisions every day that impact patients' quality of life — is especially valuable to us. These awards are the result of the collaborative work of hundreds of Solopharm employees who invest their knowledge, energy, and sincere dedication into every development. We are continuing to move forward — towards new products, new technologies, and new victories», — the company's press center emphasized.
Solopharm thanks all physicians for their profound trust and support. We will continue our work to ensure that innovative, accessible, and effective solutions become the standard of quality for medicine in Russia.